X Challenges Australia’s Expanded Social Media Ban Enforcement Powers 
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow 
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation 
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9% 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook 
 - EconoTimes)
Dublin, May 08, 2018 -- The "Stem Cells in Drug Discovery & Toxicity Screening 2018" conference has been added to ResearchAndMarkets.com's offering.
Stem Cells in Drug Discovery, and Toxicity Screening 2018 brings together researchers from around the world focusing on the emerging technologies and applications in cellular analysis.
Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies. There will also be discussions on industry and regulatory developments that are shaping the future of stem cell usage in drug discovery.
Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.
Agenda:
- 3D-Cell Culture Based Models
- Technologies in 3D-Cell Culture
- iPSC-derived Cells for Toxicity Testing & Screening
- Screening Technologies, Instrumentation and Reagents
- Stem Cells in Drug Discovery and Development
- Use of Microfluidics Organs-on-Chips for Toxicity Screening
Keynote Speakers
Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University
Mark Bradley
Professor, Schools of Chemistry and Medicine, University of Edinburgh
James Hickman
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos
Gary Gintant
Research Fellow, Abbvie
Confirmed Speakers to Date
Ulrich Broeckel
Professor of Pediatrics, Medicine and Physiology - Chief, Section of Genomic Pediatrics, Medical College of Wisconsin
Guohao Dai
Associate Professor, Department of Bioengineering, Northeastern University
Toshihiko Ezashi
Research Associate Professor, The University of Missouri
Kennedy Okeyo
Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University
Terry Riss
Global Strategic Marketing Manager Cell Health, Promega Corporation
Daniele Zink
Principal Research Scientist and Team Leader, Institute of Bioengineering and Nanotechology, Agency for Science Technology and Research (A*STAR)
For more information about this conference visit https://www.researchandmarkets.com/research/ndptbs/stem_cells_in?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Drug Abuse Screening, Stem Cells
